Home › Kanser sa Tiyan
Pag-aaral pangklinika para sa Kanser sa Tiyan na nagre-recruit sa U.S.
134 pag-aaral para sa Kanser sa Tiyan ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX42 pag-aaral
- Boston, MA32 pag-aaral
- New York City, NY31 pag-aaral
- Nashville, TN28 pag-aaral
- Los Angeles, CA22 pag-aaral
- Baldwin Park, CA21 pag-aaral
- Arlington, VA20 pag-aaral
- Dallas, TX19 pag-aaral
- San Antonio, TX19 pag-aaral
- St. Louis, MO18 pag-aaral
- Grand Rapids, MI18 pag-aaral
- Washington, DC16 pag-aaral
- Detroit, MI16 pag-aaral
- Chicago, IL16 pag-aaral
- Philadelphia, PA15 pag-aaral
- Atlanta, GA14 pag-aaral
- Pittsburgh, PA14 pag-aaral
- Portland, OR13 pag-aaral
- Orange, CA13 pag-aaral
- Cleveland, OH12 pag-aaral
- Mountain View, CA12 pag-aaral
- Denver, CO12 pag-aaral
- Madison, WI11 pag-aaral
- Oklahoma City, OK10 pag-aaral
- Orlando, FL10 pag-aaral
- Queens, NY10 pag-aaral
- Edison, NJ10 pag-aaral
- Aurora, CO10 pag-aaral
- Austin, TX10 pag-aaral
- Durham, NC10 pag-aaral
- Seattle, WA10 pag-aaral
- San Diego, CA9 pag-aaral
- Columbus, OH9 pag-aaral
- Tampa, FL9 pag-aaral
- New Haven, CT9 pag-aaral
- Omaha, NE9 pag-aaral
- Rochester, MN9 pag-aaral
- Phoenix, AZ9 pag-aaral
- Minneapolis, MN9 pag-aaral
- Kansas City, MO9 pag-aaral
Ayos sa estado
- Alabama6 pag-aaral
- Alaska4 pag-aaral
- Arizona13 pag-aaral
- Arkansas6 pag-aaral
- California68 pag-aaral
- Colorado23 pag-aaral
- Connecticut11 pag-aaral
- Delaware4 pag-aaral
- District of Columbia4 pag-aaral
- Florida38 pag-aaral
- Georgia16 pag-aaral
- Idaho3 pag-aaral
- Illinois19 pag-aaral
- Indiana10 pag-aaral
- Iowa8 pag-aaral
- Kansas8 pag-aaral
- Kentucky9 pag-aaral
- Louisiana4 pag-aaral
- Maine3 pag-aaral
- Maryland20 pag-aaral
- Massachusetts34 pag-aaral
- Michigan35 pag-aaral
- Minnesota18 pag-aaral
- Missouri23 pag-aaral
- Montana4 pag-aaral
- Nebraska9 pag-aaral
- Nevada5 pag-aaral
- New Jersey12 pag-aaral
- New Mexico5 pag-aaral
- New York38 pag-aaral
- North Carolina21 pag-aaral
- North Dakota4 pag-aaral
- Ohio24 pag-aaral
- Oklahoma11 pag-aaral
- Oregon14 pag-aaral
- Pennsylvania30 pag-aaral
- Rhode Island5 pag-aaral
- South Carolina9 pag-aaral
- South Dakota4 pag-aaral
- Tennessee30 pag-aaral
- Texas60 pag-aaral
- Utah14 pag-aaral
- Virginia27 pag-aaral
- Washington14 pag-aaral
- West Virginia4 pag-aaral
- Wisconsin18 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06219941A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07221149A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07814248A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07578571Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07360314Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07529808Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07700979IKS014 in Advanced Solid Tumors That Express HER2
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05872295Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07392892A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 19 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06586957Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06005493A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06172478A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07069712Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT05523947Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07631000Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Nagre-recruitPhase 2
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05489211Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213791A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07114601Prehabilitation in High-risk Oncologic Surgery
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07638410Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05274048A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07705334Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05267626Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07217704Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.